Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol < 50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) - Hsia, J; MacFadyen, J G; Monyak, J (J Am Coll Cardiol, 2011)
. doi:10.1016/j.jacc.2010.09.082